Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Costly care vs. cutting-edge treatments: the state of cancer today

Gene Uzawa Dorio, MD
Conditions
June 4, 2024
Share
Tweet
Share

For decades, many patients, their children, and grandkids have strived to answer, “What is cancer?” As a doctor and scientist, over the past 16 months, I have learned the latest cancer information from experts at Cedars-Sinai in Los Angeles and MD Anderson in Houston. With that, I have also become aware some patients are either denied state-of-the-art care or just kept in the dark about potential treatment because it is too costly.

First, a lesson in Cancer 101. Human cells multiply at the direction of DNA. For instance, if you have a laceration, the healing process covers the wound with a scab and then heals from below. Once complete, a “stop button” halts the cell DNA multiplication process… and the wound is healed!

Cancer is when the stop button is faulty, possibly because of a DNA mutation. Cells then multiply out of control … cancer.

Up to now, cancer treatment has utilized surgical resection, radiation, or chemotherapy, which removes or kills cancer but also adversely affects healthy cells. That’s why these treatments can get you sick from side effects.

Over the last decade, we have analyzed DNA and found mutations in cancer cells. In addition, “targeted” medicines have recently been developed that correct mutations and allow the stop button to function again, curing cancer.

Nowadays, when a biopsy of cancerous tissue is obtained, that tissue can be analyzed for “biomarkers” to determine whether there is a mutation and even suggest a drug that might stop the cancer from multiplying.

Here’s the catch: not all hospitals and insurance companies provide this analysis.

Sixteen months ago, cancer was found in my partner, Robin, and Cedars-Sinai provided not only a pathology report but also her biomarker analysis. This revealed a mutation and even designated medication that might be used to treat it.

This information was used by doctors at Cedars-Sinai and MD Anderson to contour appropriate care using targeted medication against her cancer. Every day, new medication is developed, and hopefully, one day, all cancers might be treated with targeted drugs.

Let’s revisit the inequality in health care. Some hospitals and insurance companies do not offer biomarker analysis for their patients. The reason? The cost.

Fortunately, the extra cost for biomarker analysis I have found in my research is under $300. Not much to save a life! But the overall treatment cost comes later as the new targeted cancer medication could be as much as $20 to 30,000 per month. Aha! That’s why!

Right now, though, many pharmaceutical companies are providing significant discounts for these targeted medications as they are still gathering evidence-based data to use these drugs in the future as first-line treatment, possibly replacing surgery, radiation, and chemotherapy.

Here’s another piece of information that most patients and doctors don’t know: New tests examine blood for cancer cells, ctDNA (circulating tumor DNA). Robin is in a clinical trial at MD Anderson, which they used in conjunction with a PET/CT scan revealing metastasis and consequential use of targeted cancer treatment.

ADVERTISEMENT

After four weeks of targeted treatment, a repeat PET/CT scan and ctDNA blood test revealed undetectable cancer. Four weeks!

Because of side effects, she had to stop the medication and later go to a lower dose, but at least we saw a halt in the cancer cell multiplication. Indeed, this treatment seems promising, guided by the up-to-date initial information from the biomarker analysis and ctDNA blood test. Without this information, we would not have had much hope.

Therefore, adding to Cancer 101, if you have been recently diagnosed with cancer, you and your doctor should do the following:

  • Look at the tissue biopsy pathology report for a biomarker analysis. It could be designated using other terminology like genetic testing, tumor testing, genomic or genomic profiling, molecular or molecular profiling, somatic testing, or tumor subtyping. At Cedars-Sinai, it was called CS Comprehensive Cancer Plus;
  • If a biomarker analysis has not been done, ask if insurance will cover the cost;
  • If they won’t, contact the insurance company and ask for approval;
  • If they don’t pay for it, open your wallet as it will be the best investment you could make for yourself or a loved one (as I mentioned, right now, it is usually under $300);
  • If there is a biomarker analysis, you must find a specialist (oncologist) who can best interpret the information. Typically, they are at teaching institutes. Right now, most primary care doctors are not up-to-date in deciphering this data;
  • Ask your doctor if a ctDNA blood test is available, which could provide valuable information concerning your workup or treatment plan.

The road you then travel will be at the edge of modern technology, so you might consider information obtained not just from your doctor but also online (although vetting is essential);

We also joined online social and support groups, which are very helpful, especially emotionally.

In California, a recent proposal signed into law in 2023, SB 496, mandates cancer pathology reports in MediCal patients (Medicaid) have tumor biomarker analysis provided.

Frustratingly, only a small percentage of VA pathology reports have these analyses done, which does not reflect good enough care for those who have served our county. Maybe we can correct this legally on a federal level in 2024 or 2025.

Cancer is the second leading cause of death in the United States. New medical technology can lower these numbers, but the public must have adequate information to make appropriate medical decisions. Cost will always play a role, but every citizen must have a Cancer 101 education and an equal opportunity to receive treatment.

Hopefully, my grandchildren will one day ask me, “What was cancer, Grandpa?”

Gene Uzawa Dorio is an internal medicine physician who blogs at SCV Physician Report.

Prev

Resident struggles: How hierarchical health care systems impact IMGs

June 4, 2024 Kevin 0
…
Next

Why every picture tells a medical story

June 4, 2024 Kevin 0
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Resident struggles: How hierarchical health care systems impact IMGs
Next Post >
Why every picture tells a medical story

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Gene Uzawa Dorio, MD

  • Pope Francis dies at 88. What his care reveals about America’s failing hospitals.

    Gene Uzawa Dorio, MD
  • When saving lives leads to losing your own

    Gene Uzawa Dorio, MD
  • The business of medicine: How hospitals are putting profits over patients

    Gene Uzawa Dorio, MD

Related Posts

  • Why new cancer treatments cannot save us

    Yongjia Wang
  • A letter to a cancer patient in palliative care

    Alison Vasa
  • “System-ness”: the key to successful health care transformation

    Robert Pearl, MD
  • Cancer care costs everyone too much. What can we do about it?

    Andrew Hertler, MD
  • How value-based care can address health inequities

    Michael Poku, MD, MBA
  • Integrated care is the key to optimizing cancer outcomes

    Chelsey Lindner, PharmD

More in Conditions

  • Hope is the lifeline: a deeper look into transplant care

    Judith Eguzoikpe, MD, MPH
  • From hospital bed to harsh truths: a writer’s unexpected journey

    Raymond Abbott
  • Bird flu’s deadly return: Are we flying blind into the next pandemic?

    Tista S. Ghosh, MD, MPH
  • “The medical board doesn’t know I exist. That’s the point.”

    Jenny Shields, PhD
  • When moisturizers trigger airport bomb alarms

    Eva M. Shelton, MD and Janmesh Patel
  • Medicaid cuts are quietly fueling the diabetic kidney failure crisis

    Jane Zill, LICSW
  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Bureaucracy over care: How the U.S. health care system lost its way

      Kayvan Haddadan, MD | Physician
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • When errors of nature are treated as medical negligence

      Howard Smith, MD | Physician
    • Physician job change: Navigating your 457 plan and avoiding tax traps [PODCAST]

      The Podcast by KevinMD | Podcast
    • The hidden chains holding doctors back

      Neil Baum, MD | Physician
    • Hope is the lifeline: a deeper look into transplant care

      Judith Eguzoikpe, MD, MPH | Conditions
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • From hospital bed to harsh truths: a writer’s unexpected journey

      Raymond Abbott | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Bureaucracy over care: How the U.S. health care system lost its way

      Kayvan Haddadan, MD | Physician
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • When errors of nature are treated as medical negligence

      Howard Smith, MD | Physician
    • Physician job change: Navigating your 457 plan and avoiding tax traps [PODCAST]

      The Podcast by KevinMD | Podcast
    • The hidden chains holding doctors back

      Neil Baum, MD | Physician
    • Hope is the lifeline: a deeper look into transplant care

      Judith Eguzoikpe, MD, MPH | Conditions
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • From hospital bed to harsh truths: a writer’s unexpected journey

      Raymond Abbott | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Costly care vs. cutting-edge treatments: the state of cancer today
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...